DCF — ASPIRUS RHINELANDER HOSPITAL
Enterprise Value: $65.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$65.3M
Enterprise Value
$30.1M
PV of Cash Flows
$35.2M
PV of Terminal Value
$56.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $-374.4M | $-1.9M | 1.0% | $12.1M | $11.0M |
| Year 2 | $-385.6M | $-5.8M | 1.0% | $9.6M | $7.9M |
| Year 3 | $-397.2M | $-9.9M | 3.0% | $6.9M | $5.2M |
| Year 4 | $-409.1M | $-12.3M | 3.0% | $5.0M | $3.4M |
| Year 5 | $-421.4M | $-13.7M | 3.0% | $4.1M | $2.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $65.3M. Terminal value accounts for 54% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$-363.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5